Gene editing was a new idea in the mid-1970s. So when Harvard and MIT planned new research in recombinant DNA, alarm bells went off. "People were worried about a 'Frankengene,'" says Lydia Villa-Komaroff, then a freshly minted PhD. Amidst a political circus, the city of Cambridge, Massachusetts banned research into recombinant DNA, forcing scientists like Villa-Komaroff into exile. But that turned out to be just the prelude to a breakthrough. In this episode, Dr. Villa-Komaroff tells Emily Kwong the story of overcoming the skeptics and coaxing bacteria into producing insulin for humans.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Short Wave
Transcribed and ready to explore now
Parasites Have Haunted Us For Millions Of Years
24 Oct 2025
Short Wave
Migrating Birds Have a Big, Clear Problem
22 Oct 2025
Short Wave
We Have the Cure. Why is Tuberculosis Still Around?
21 Oct 2025
Short Wave
Should Scientists Genetically Engineer Wild Species?
20 Oct 2025
Short Wave
Science Says Quitting Smoking At Any Age Is Good For The Brain
17 Oct 2025
Short Wave
What Happens When You're Under Anesthesia?
15 Oct 2025
Short Wave